¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Ascorbic Acid Coated 96% Type SC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • calcium ethylenediaminetetraacetic acid
    Ä®½·¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
  • chamber acid
    ¿¬½ÇȲ»ê
  • chenodeoxycholic acid
    Äɳ뵥¿Á½ÃÄÝ»ê
  • chitonic acid
    Űſ»ê
  • cholic acid
    ´ãÁó»ê
  • delta-aminolevulinic acid
    µ¨Å¸¾Æ¹Ì³ë·¹ºÒ¸°»ê
  • deoxycholic acid
    µ¥¿Á½ÃÄÝ»ê
  • deoxyribonucleic acid
    µ¥¿Á½Ã¸®º¸ÇÙ»ê, DNA
  • desoxyribonucleic acid
    µ¥¿Á½Ã¸®º¸ÇÙ»ê, DNA
  • dibasic acid
    ÀÌ¿°±â»ê
  • dicarboxylic acid
    µðÄ«¸£º¹½Ç»ê
  • dilute acid
    ¹±Àº»ê
  • essential amino acid
    Çʼö¾Æ¹Ì³ë»ê
  • essential fatty acid
    ÇʼöÁö¹æ»ê
  • ethylenediamine tetraacetic acid
    ¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • corrosive acid
    ºÎ½Ä»ê
  • cyanuric acid
    ½Ã¾Æ´©¸£»ê
  • cyclopaldic acid
    ½ÃŬ·ÎÆÈµå»ê
  • deoxycholic acid
    µð¿Á½ÃÄݸ°»ê
  • deoxyribonucleic acid
    µð¿Á½Ã¸®º¸ÇÙ»ê, µð¿£¿¡ÀÌ
  • desoxyribonucleic acid
    (¢¡deoxyribonucleic acid) µð¿Á½Ã¸®º¸ÇÙ»ê, µð¿£¿¡ÀÌ
  • dibasic acid
    ÀÌ¿°±â»ê
  • dicarboxylic acid
    µðÄ«¸£º¹½Ç»ê
  • dilute acid
    ¹±Àº»ê
  • essential amino acid
    Çʼö¾Æ¹Ì³ë»ê
  • essential fatty acid
    ÇʼöÁö¹æ»ê
  • ethylenediamine tetraacetic acid
    ¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
  • fatty acid
    Áö¹æ»ê
  • fibril acid
    ¼¶À¯»ê
  • fixed acid
    °íÁ¤»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • acetic acid
    ¾Æ¼¼Æ®»ê, ÃÊ»ê(õ³ß«).
  • acetic acid
    ¾Æ¼¼Æ®»ê
  • acetoacetic acid
    ¾Æ¼¼Å侯¼¼Æ®»ê.
  • acetoacetic acid
    ¾Æ¼¼Å侯¼¼Æ®»ê
  • acetylsalicylic acid
    ¾Æ¼¼Æ¿»ì¸®½Ç»ê
  • acid phosphatase
    »êÀλêÈ¿¼Ò
  • acid alcohol
    »ê¼º¾ËÄÚ¿Ã.
  • acid ash diet
    »ê¼º½ÄÀÌ.
  • acid aspiration syndrome
    À§»ê ÈíÀÔ ÁõÈıº
  • acid bath
    »ê¿å(ß«é±).
  • acid burn
    »ê¼º¿Ü»ó, »ê¼ºÈ­»ó.
  • acid burn
    »ê¼ºÈ­»ó
  • acid catalyser
    »êÃ˸Å(ß«õºØÚ).
  • acid challenge test
    »ê Åõ¿©½ÃÇè
  • acid citrate dextrose
    »ê ±¸¿¬»ê¿°Æ÷µµ´ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • lymphatic type
    ¸²ÇÁÇü(¡­úþ).
  • mating type
    ±³¹èÇü
  • men type
    MEN Çü(¡­ û¡)
  • meningeal type
    ¼ö¸·Çü(âÐØ¯úþ).
  • metaphyseal dysostosis dominant type
    °ñ °£´Ü¼º À̰ñÁõ ¿ì¼ºÇü(ÍéÊÏÓ®àõì¶ÍéñøéÐàõúþ).
  • metaplastic bone (type)
    È­»ý°ñ(Çü)(ûùßæÍéû¡).
  • mixed type of artery
    È¥ÇÕÇüµ¿¸Æ
  • mobile type diagnostic X ray apparatus
    À̵¿Çü Áø´Ü X¼± ÀåÄ¡
  • monocytic type
    ´ÜÇÙ±¸Çü(¡­û¡).
  • monocytic type
    ´ÜÇÙ±¸Çü(Ó¤ú·Ï¹û¡)
  • monocytic type
    ´ÜÇÙ±¸Çü(?Ì´).
  • muscular type of artery
    ±ÙÀ°Çüµ¿¸Æ
  • muscular type of lymphatic vessel
    ±ÙÀ°Çü¸²ÇÁ°ü
  • muscular type of vein
    ±ÙÀ°ÇüÁ¤¸Æ
  • mutation, plaque-type
    ÇöóÅ©Çü µ¹¿¬º¯ÀÌ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • cevitaminic acid
    ¼¼ºñŸ¹Î »ê(ß«)
  • charged polar amino acid
    ±Ø¼º(пàü) ¾Æ¹Ì³ë»ê(ß«)
  • chaulmoogric acid
    Â÷¿ï¹«±×¸£»ê(ß«)
  • chenic acid
    þ»ê(ß«)
  • chenodeoxycholic acid
    Ű³ëµð¿Á½ÃÄݸ° »ê(ß«)
  • p-chloromercuribenzoic acid
    p-Ŭ·Î·Î¸ÓÅ¥¸®º¥Á¶»ê(ß«)
  • choleic acid
    ÄÝ·¹»ê(ß«)
  • cholic acid
    ÄÝ»ê(ß«)
  • chorismic acid
    ÄÚ¸®½¿»ê(ß«)
  • citric acid
    ½ÃÆ®¸£»ê(ß«)
  • citric acid cycle
    ½ÃÆ®¸£»êȸ·Î(ß«üÞÖØ)
  • concerted acid-base catalysis
    Çùµ¿ »ê¿°±â Ã˸Å(úðÔÒß«ç¤ÐñõºØÚ)
  • conjugate acid-base pair
    ¦ÁöÀº »ê¿°±â½Ö(ß«ç¤Ðñäª)
  • conservative amino acid replacement
    "º¸Á¸¼º(ÜÁðíàõ) ¾Æ¹Ì³ë»ê ´ëÄ¡(ÓÛöÇ), (ÔÒ) conservative substitution"
  • cortoic acid
    ÄÚ¸£Æ¼¼Ö»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
NA Avogadro constant or number; nalidixic acid; Narcotics Anonymous; network administrator; neuraminida...
NAA N-acetyl aspartate; naphthaleneacetic acid; neutral amino acid; neutron activation analysis; neutrop...
TCA T-cell A locus; terminal cancer; tetracyclic antidepressant; total cholic acid; total circulating al...
TPA tannic acid, polyphosphomolybdic acid, and amino acid; 12-0-tetradecanoyl-phorbol-13-acetate; third-...
UA absorption unsharpness; ultra-audible; ultrasonic arteriography; umbilical artery; unauthorized abse...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
AAV Adeno-associated virus type 2
AAV-2 Adeno-associated virus type 2
Ad12 Adenovirus type 12
Ad3 Adenovirus type 3
Ad4 Adenovirus type 4
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acid-base
    »ê ¿°±â
  • acid-base balance disturbance
    »ê ¿°±â ÆòÇü ÀÌ»ó
    »ê°ú ¿°±âÀÇ ÆòÇüÀÌ ±úÁø »óÅÂ.
  • acid-base compensation
    »ê ¿°±â º¸»ó
  • acid-base indicator
    »ê ¿°±â Áö½Ã¾à
  • acid-fast nonmotile rod
    Ç׻꼺 ºñ¿îµ¿¼º °£±Õ
  • acid-gel application
    °ÖÇü »ê Àû¿ë
  • adenylic acid deaminase
    ¾Æµ¥´Ò»ê Å»¾Æ¹Ì³ë È¿¼Ò
  • aldobionic acid
    ¾Ëµµºñ¿Â»ê
    C11H19O10COOH. ±× ¼ººÐ´çÀÇ Çϳª·Î¼­ ¿ì·Ð»êÀ» ÇÔÀ¯Çϰí ÀÖ´Â ÀÌ´ç·ùÀ̸ç, ¿©·¯ Á¾·ùÀÇ ½Ä¹°¼º °í¹«¿Í ƯÁ¤ÇÑ º´¿øÃ¼ Áß¿¡ Á¸ÀçÇÑ´Ù. Æó·Å±Õ 3ÇüÀÇ Æ¯¼ö ´Ù´ç·ùÀÇ °¡¼öºÐÇØ¿¡ ÀÇÇØ¼­ ¾òÀ» ¼ö ÀÖ´Ù.
  • allokainic acid
    ¾Ë·ÎÄ«ÀÎ »ê
  • alloxyproteic acid
    ¾Ë·Ï½Ã ´Ü¹é»ê
    ¶§¶§·Î ´¢ Áß¿¡ ¹è¼³µÇ´Â À¯È² ÇÔÀ¯ È­ÇÕ¹°.
  • alpha-oxynaphthoic acid
    ¾ËÆÄ-¿Á½Ã³ªÇÁÅä»ê
    °áÁ¤¼ºÀÇ »ê,OHC10H6COOH.°ú°Å¿¡´Â ¹æºÎÁ¦, ¹æÃëÁ¦·Î »ç¿ëµÇ¾ú´Ù.
  • amino acid L-tryptophan
    ¾Æ¹Ì³ë»ê L-Æ®¸³ÅäÆÇ
  • aminoacetic acid
    ¾Æ¹Ì³ë¾Æ¼¼Æ®»ê, ¾Æ¹Ì³ëÃÊ»ê
    ºñÇʼö ¾Æ¹Ì³ë»ê, NH2CH2COOH. ¸¹Àº ´Ü¹éÁúÀÇ ±¸¼º ¼ººÐÀ¸·Î Á¸ÀçÇÑ´Ù. ÇÕ¼ºµÇ°í ÀÖÀ¸¸ç À§ Á¦»êÁ¦¿Í º¸Ãæ½ÄǰÀ¸·Î »ç¿ëµÇ¾îÁø´Ù. ¶ÇÇÑ ¿©·¯ °¡Áö ±ÙÀ°º´ ¹× ¸»ÃÊÇ÷°ü ºÎÀüÁõÀÇ Ä¡·á¿¡µµ »ç¿ëµÈ´Ù.
  • aminobenzoic acid
    ¾Æ¹Ì³ë ¾È½ÄÇâ »ê
    C7H7NO2. ½Ä¹°°ú µ¿¹°Á¶Á÷¿¡ ³Î¸® ºÐÆ÷Çϸç, ºñŸ¹Î B±ºÀÇ ±¸¼º ¼ººÐ¿¡ °ü°èµÈ´Ù. ¼³ÆÄÁ¦ÀÇ Á¤±ÕÀÛ¿ëÀ» ¹«È¿È­½ÃŲ´Ù.
  • arachidonic acid
    ¾Æ¶ó۵·»ê
    1. °íµµÀÇ ºÒÆ÷È­ Çʼö Áö¹æ»ê. CH3
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
South African type porphyria Porphyria characterised by abdominal pain and neuropsychiatric abnormalities, by dermal sensitivity to light and mechanical trauma, by increased faecal excretion of proto-and coproporphyrin, and by increased urinary excretion of d-aminolevulinic acid, porphobilinogen, and porphyrins; due to a deficiency of protoporphyrinogen oxidase; autosomal dominant inheritance.
Synonym: protocoproporphyria hereditaria, South African type porphyria.
(05 Mar 2000)
Naegeli type of monocytic leukaemia A variant of granulocytic leukaemia with monocytosis in the peripheral blood.
Synonym: Naegeli type of monocytic leukaemia.
(05 Mar 2000)
name bearing type <zoology> The type genus, type species, holotype, lectotype, series of syntypes, neotype, type slide, or hapantotype, that provides the objective standard of reference whereby the application of the name of a taxon can be determined.
(09 Jan 1998)
neoplasms by histologic type A collective term for the various histological types of neoplasms. It is more likely to be used by searchers than by indexers and catalogers.
(12 Dec 1998)
stream-type fish Fish that rear for a year or more in a stream.
(09 Oct 1997)
Nezelof type of thymic alymphoplasia Synonym: cellular immunodeficiency with abnormal immunoglobulin synthesis.
(05 Mar 2000)
s-type cholinesterase <enzyme> An enzyme that breaks down acetylcholine tostop its action.
(22 May 1997)
S type lectin <protein> One of two classes of lectin produced by animal cells. The classification of animal lectins into two classes, the other being the C type, was originally proposed by K.Drickamer.
The carbohydrate binding activity of the S type lectins requires their cysteines to have free thiols and does not need divalent cations (c.f. C type lectins). They mostly have molecular masses in the range 14-16 kD and often form dimers and higher oligomers. The carbohydrate recognition domain contains a number of critically conserved amino acids and largely binds to _ galactosides. S type lectins certainly occur as cytoplasmic proteins but the existence of extracellular S type lectins is still a matter of debate.
(18 Nov 1997)
nomenclatural type The constituent element of a taxon to which the name of the taxon is permanently attached; the type of a species is preferably a strain (in special cases it may be a description, a preserved specimen or preparation, or an illustration); the type of a genus is a species; and the type of an order, family, or tribe is the genus on whose name the name of the higher taxon is based.
(05 Mar 2000)
nutritional type cerebellar atrophy A restricted type of cerebellar cortical degeneration, affecting particularly the Purkinje cells of the anterior and superior vermis; probably caused by thiamin deficiency; most frequently seen in chronic alcoholics and then called alcoholic cerebellar degeneration.
(05 Mar 2000)
delayed type hypersensitivity <immunology> Hypersensitivity (increased reaction by the body to a foreign substance such as an antigen or allergen) that does not appear until 24 to 48 hours after the body is exposed to the foreign substance.
(09 Oct 1997)
Swiss type agammaglobulinaemia Group of rare congenital disorders characterised by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an x-linked or autosomal recessive defect. About half of the patients with autosomal recessive scid are deficient in the enzyme adenosine deaminase.
(12 Dec 1998)
deoxyribonucleases, type III site-specific <enzyme> Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as atpases. They exist as complexes with modification methylases of similar specificity.
The systems recognise specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.5
(12 Dec 1998)
deoxyribonucleases, type II site-specific <enzyme> Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognise specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.4
(12 Dec 1998)
deoxyribonucleases, type I site-specific <enzyme> Enzyme systems containing three different subunits and requiring ATP, s-adenosylmethionine, and magnesium for endonucleolytic activity to give random double-stranded fragments with terminal 5'-phosphates. They function also as DNA-dependent atpases and modification methylases, catalyzing the reactions of EC 2.1.1.72 and EC 2.1.1.73 with similar site-specificity. The systems recognise specific short DNA sequences and cleave at sites remote from the recognition sequence. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.3
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á